Category: Clinical Breakthroughs
-
New Wireless Sweat Patch May Improve Cystic Fibrosis Treatment
A new wireless and wearable device developed by Northwestern Medicine scientists measures specific biomarkers in a person’s sweat and has the potential to improve clinical decision-making for cystic fibrosis, as detailed in a recent study published in the Proceedings of the National Academy of Sciences.
-
New Drug Shows Promise in Treating a Common Cause of Hypertension
A novel drug may significantly improve outcomes for a subset of patients with high blood pressure, according to findings published in The New England Journal of Medicine.
-
Innate Immune ‘Mismatch’ Could Transform Kidney Transplant Outcomes
A genetic mismatch may influence kidney transplant success and could inform how donor-recipient compatibility is assessed, according to a study published in Science Translational Medicine.
-
What Makes a SuperAger?
Over a quarter-century of research, Northwestern scientists have been studying individuals over eighty with memory capacity of people at least three decades younger, to identify the biological and behavioral traits associated with “SuperAging.”
-
Predicting Risk in Children with Heart Defects
A multi-center study has identified critical risk factors that increase the likelihood of death in children with Fontan circulatory failure who are awaiting or have recently undergone heart transplantation, according to findings published in Circulation.
-
Asthma Drug Blocks Food Allergy Reactions in Mice
A drug already FDA-approved for asthma was found to nearly eliminate life-threatening allergic reactions to food allergens in mice, according to a new Northwestern Medicine study published in the journal Science.
-
Most U.S. Adults Have Hearts Older than Their Actual Age
Northwestern scientists have created a free online tool that calculates a person’s “heart age” based on their risk for cardiovascular disease using routine health data, according to a study published in JAMA Cardiology.
-
Successful Gene Editing Demonstrated for a Rare Neurodevelopmental Disorder
Scientists have implemented a novel gene-editing approach that may be an effective treatment for alternating hemiplegia of childhood (AHC), a rare neurodevelopmental disorder in children, according to a recent study published in Cell.
-
Combination Approach May Improve Cancer Treatment Efficacy
Northwestern Medicine investigators have discovered a new combination approach that may improve the efficacy of MYC inhibitor drugs for treating aggressive and treatment-resistant cancers, according to a recent Northwestern Medicine study published in Science Advances.
-
‘Dancing Molecules’ Treatment Receives FDA Orphan Drug Designation
“Dancing molecules,” a promising new treatment for acute spinal cord injuries developed at Northwestern University, has received Orphan Drug Designation from the U.S. Food and Drug Administration.
